5-Phenyloxazole>95.0%(GC)1g

potassium 4-isopropyl-1,3-thiazole-2-carboxylate, 95.0%, 25g

2,3-Dihydro-1H-pyrrolo[3,4-c]pyridine dihydrochloride, 95.0%, 10g

4-(6-Chloropyrimidin-4-yl)-N-methylthiazol-2-amine, 95.0%, 250mg

[S(R)]-N-[(R)-[2-(Dicyclohexylphosphino)phenyl]-2-naphthalenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%, 100mg

5-AMINOISOTHIAZOLE-4-CARBOXAMIDE, 95.0%, 100mg

2-methoxy-5-{[(propan-2-yl)amino]methyl}phenol, 95.0%, 10g

(S)-(1-Methylazetidin-2-yl)methanamine dihydrochloride, 97.0%, 100mg

N-Hexadecylbenzamide, 95.0%, 250mg

Diethyl (2-((4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)amino)-2-oxoethyl)phosphonate, 96%, 250mg

Flat flange reaction vial DURAN®, DN 150, 10000 ml, 184 mm, 240 mm, Height, 410 mm, 1 Piece

2-Amino-6-phenylpyridine, 98.0%, 10g

2-tert-Butyl-5-chloro-6-methylpyrimidin-4-ol, 95.0%, 5g